No Data
Express News | China Health Technology - Bu Xue Re- Designated as an Executive Director
CN HEALTH TECH: Interim Report 2024
CN HEALTH TECH (01069): Li Zhiqiang has been appointed as the CEO of Genmou Biotechnology.
CN HEALTH TECH Group (01069) announced that Li Zhi Liang has been appointed as the company’s wholly-owned subsidiary Genmou (Shenzhen...
CN HEALTH TECH (01069) announced its interim results, with a net income of 4.978 million yuan, a decrease of 97.53% year-on-year.
CN HEALTH TECH (01069) released its interim results for the six months ending December 31, 2024, the group...
CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED 31 DECEMBER 2024
CN HEALTH TECH (01069.HK) intends to hold a Board of Directors meeting on February 28 to approve the interim results.
On February 18, Glonghui reported that CN HEALTH TECH (01069.HK) announced that the Board of Directors will hold a meeting on February 28, 2025 (Friday) to consider and approve the group's interim performance announcement for the six months ending December 31, 2024, as well as to consider the proposal to pay an interim dividend (if any).
